✦ LIBER ✦

Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair

✍ Scribed by Ireneusz Majsterek; Tomasz Sliwinski; Tomasz Poplawski; Dariusz Pytel; Michal Kowalski; Artur Slupianek; Tomasz Skorski; Janusz Blasiak

Book ID: 116759059
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 233 KB
Volume: 603
Category: Article
ISSN: 1383-5718
DOI: 10.1016/j.mrgentox.2005.10.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

STI-571 (Imatinib Mesylate) Enhances the

STI-571 (Imatinib Mesylate) Enhances the Apoptotic Efficacy of Pyrrolo-1,5-Benzoxazepine-6, a Novel Microtubule-Targeting Agent, in Both STI-571-Sensitive and -Resistant Bcr-Abl-Positive Human Chronic Myeloid Leukemia Cells

✍ Greene, L. M.; Kelly, L.; Onnis, V.; Campiani, G.; Lawler, M.; Williams, D. C.; 📂 Article 📅 2007 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 463 KB